Clinical Trials Directory

Trials / Completed

CompletedNCT00937014

Assessment of Growth of Infants Fed a New Formula

Assessment of Growth of Infants Fed a Starter Formula With a Whey-Isolate Enriched in Lactoferrin

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
180 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
11 Days – 17 Days
Healthy volunteers
Accepted

Summary

The purpose of this clinical trial is to assess growth (rate of weight gain in grams per day) of infants fed an infant formula with a whey isolate enriched with lactoferrin, during the first four months of life as compared to infants fed a standard infant formula.

Conditions

Interventions

TypeNameDescription
OTHERstandard infant formulaStandard infant formula given during the first 9 months of life, as per standard requirement
OTHERTest formulaTest formula enriched in lactoferrin given during the first 9 months of life, as per standard requirement.

Timeline

Start date
2010-02-01
Primary completion
2013-06-01
Completion
2013-06-01
First posted
2009-07-10
Last updated
2013-06-26

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00937014. Inclusion in this directory is not an endorsement.